CASSS – Sharing Science Solutions is excited to announce the election of Nina S. Cauchon and J.R. Dobbins to the Board of Directors. CASSS board members are elected by the Associate Directors of the organization, a group of volunteers who have contributed significantly to the association.
Reflecting on why she chose to seek a seat on the board, Cauchon believes, “From inception, CASSS has long played a vital role in bridging science, innovation, and global regulatory perspectives to help bring important medicines to patients. Its greatest strength is the diverse scientific community it has built, and it is essential that CASSS continues educating and engaging the next generation of leaders while expanding global regulatory participation and adapting to emerging technologies and modalities. I am motivated to contribute my regulatory, technical, and global leadership experience to help ensure CASSS remains an agile and impactful organization for the future”.
J.R. shares why CASSS is important to the future, “CASSS plays a critical role in advancing global knowledge sharing at the intersection of science and regulation, and it’s important that we continue to evolve alongside the industry. I am passionate about engaging the next generation of members by meeting them where they are and adapting CASSS’ approach accordingly, as well as sustaining the strong regulatory engagement that has been foundational to CASSS’ success. Looking ahead, I believe CASSS must remain at the forefront of innovation by expanding how we support emerging modalities and technologies. Initiatives such as the AAV Virtual Summit and increased focus on bioconjugates demonstrate how CASSS can test new models and continue shaping the future of bioproduct development”.
Nina S. Cauchon currently serves as Director of Regulatory Affairs, CMC at Amgen Inc. She holds a B. Pharm degree from the University of Mumbai and earned her PhD in pharmacy from Purdue University.
Cauchon has extensive experience across scientific and regulatory member-based organizations, including ISPE, AAPS, IQ, IFPAC, and DIA, where she has served as a speaker, panelist, moderator, committee member, and organizer, as well as on the ISPE International Board of Directors. Her engagement also extends to key trade organizations such as PhRMA, BIO, and ICH. In addition, she regularly lectures at academic institutions, including the University of Southern California.
A long-standing contributor to CASSS and Associate Director, Cauchon has been actively involved with both the WCBP Symposium and the CMC Strategy Forum North America Scientific Organizing Committees. She currently serves as Industry Chair for WCBP 2026, and throughout her CASSS tenure led workshops and panel discussions and contributed to white papers, supporting CASSS’s mission of advancing scientific dialogue and regulatory collaboration across the biopharmaceutical community.
J.R. Dobbins currently serves as Associate Vice President, Global Regulatory Affairs, CMC Biotechnology at Eli Lilly and Company. He earned a Bachelor of Science in chemistry from Ball State University and a Masters of Science in Biochemistry from Purdue University. He has extensive experience in the development and regulation of biotherapeutics and expertise with specification strategies through his role as chair of the specification committee at Eli Lilly and Company. Dobbins participates in PhRMA and EFPIA initiatives related to specifications including co-author of a paper on patient centric specifications (PhRMA) and is a current member of the EFPIA work group focused on the ongoing revision to the ICH guidelines on Specifications (ICH Q6a/b).
As a CASSS leader, Dobbins has served as a CASSS Associate Director and held numerous leadership and advisory roles across the organization. His contributions include service on the CMC Strategy Forum North America Steering Committee, WCBP Organizing Committee, CGTP Steering Committee and the Global CMC Strategy Forum Steering Committee. He also chaired the inaugural AAV Virtual Summit in 2024 and was a co-founder of the Midwest Discussion Group.